RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
RARX
Delisted
RARX was delisted on the 1st of April, 2020.
66 hedge funds and large institutions have $131M invested in Ra Pharmaceuticals, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 18 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
+2
Holders Change %
+3.13%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
20
Reduced
18
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SCA
76
Secor Capital Advisors
New York
| – | -$203K | -13,889 | Closed |
|
|
CS
77
Credit Suisse
Zurich,
Switzerland
| – | -$148K | -10,151 | Closed |
|
78
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$16K | -1,069 | Closed |
|
79
UBS Group
Zurich,
Switzerland
| – | -$6K | -393 | Closed |
|
|
MA
80
MUFG Americas
New York
| – | -$2K | -150 | Closed |
|